Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05808699 · ClinicalTrials.gov registry record
Camera Qualification Study
A clinical trial of Diabetic Retinopathy, sponsored by Digital Diagnostics.
- Active
- Registry status
- 626
- Enrollment target
- 9
- Study locations
NCT05808699 is a study of Diabetic Retinopathy that is active but no longer recruiting, run by Digital Diagnostics. The registered enrollment target is 626 participants, below the 1,665-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (62% lower). The trial reports 9 study locations across 6 states.
The verdict
NCT05808699, a study of Diabetic Retinopathy, is active but no longer recruiting, sponsored by Digital Diagnostics.
- ACTIVE NOT RECRUITING
- Registry status
- 626 participants
- Enrollment target
- 9
- Study locations
Study Summary
A multi-center study to evaluate the performance of an automated device for the detection of diabetic retinopathy with the use of an additional fundus camera with IDx-DR.
Conditions Studied
Interventions
- DEVICE handheld fundus camera
Study Locations (9)
California
- Infinity Clinical Research - Norco
- Dream Team - Pomona
Florida
- East Cost Institute for Research - Jacksonville
- Ocean Wellness Center - Miami Gardens
Texas
- Allure Health - Friendswood
- Mt. Olympus Medical Research - Sugar Land
Mississippi
- Olive Branch Family Medical Center - Olive Branch
Montana
- Logan Health - Kalispell
North Dakota
- Lillestol Research, LLC - Fargo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 626 participants |
| Start Date | 2023-03-03 |
| Est. Completion | 2025-01-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05808699
The ClinicalTrials.gov registry entry for NCT05808699 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 626 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,665-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (62% lower). The listed sponsor is Digital Diagnostics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Retinopathy appearing as the primary indexed condition, and to 1 intervention - of which handheld fundus camera is the first listed.
NCT05808699 reports 9 study locations spanning 6 distinct geographic areas - top geographies include California, Florida, Texas.
Frequently Asked Questions
What is clinical trial NCT05808699 about?
NCT05808699 is a clinical study titled "Camera Qualification Study". A multi-center study to evaluate the performance of an automated device for the detection of diabetic retinopathy with the use of an additional fundus camera with IDx-DR.
What is the current status of trial NCT05808699?
This trial is currently active not recruiting. The enrollment target is 626 participants. The study started on 2023-03-03. Estimated completion is 2025-01-30.
What conditions does trial NCT05808699 study?
This clinical trial studies the following conditions: Diabetic Retinopathy.
What interventions are being tested in trial NCT05808699?
The interventions under investigation include: handheld fundus camera (DEVICE).
Who is sponsoring clinical trial NCT05808699?
This trial is sponsored by Digital Diagnostics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05808699 being conducted?
This trial has 9 study locations across California, Florida, Mississippi, Montana, North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Retinopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fenofibrate for Prevention of DR Worsening
RECRUITING · Phase 3
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
RECRUITING
-
Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
RECRUITING · NA
-
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
RECRUITING · Phase 2
-
Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.